Prosomnus Inc (OSA) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access OSA Annual Cash Flow →
Quarterly cash flow trends provide additional context on Prosomnus Inc's liquidity and ability to support ongoing operations and capital needs.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2024)
6 Months
(Mar 31 2024) (Dec 31 2023) (Sep 30 2023) (Jun 30 2023)
Operating Activities
Income-11.74
Depreciation & amortization0.74
Amortization of Other Assets0.00
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability-0.62
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.57
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.00
Share-based Compensation0.87
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants-0.10
Forgiveness Of Ppp Loans-
Finance Lease Right Of Use Asset Amortization0.58
Operating Lease Right Of Use Asset Amortization Expense0.18
Non Cash Interest1.17
Fair Value Adjustment Of Debt-5.89
Gain Loss On Financing Transactions-
Operating Lease Impairment Loss-
Non Cash Reorganization Items10.08
Income taxes0.00
Losses/ -gains on Investments net0.00
Increase (Decrease) in Accounts Receivable-0.68
Increase (Decrease) in Accounts Payable-1.44
Increase (Decrease) in Accrued Liabilities-1.72
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-2.22
Other Working Capital0.04
Other Noncash Expense0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.15
Discontinued operations0.00
Net Cash flow from Operating Activities-10.34
Investing Activities
Capital Expenditures-0.44
Sale of Capital Items0.00
Short-term Investments Proceeds0.00
Short-term Investments Acq.0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-0.44
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-7.06
Principal Payments On Equipment Financing Obligation-0.03
Proceeds From Paycheck Protection Program Loan-
Proceeds From Subordinated Loan And Security Agreement-
Repayments Of Subordinated Loan And Security Agreement-
Proceeds From Issuance Of Unsecured Subordinated Promissory Notes Bridge-
Proceeds From Subscription Agreements-
Proceeds From Issuance Of Debtor In Possession Term Loan9.50
Finance Lease Principal Payments-0.46
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents7.06
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities9.01
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-10.77
Total Cash Flow-1.76
4 historic quarters locked

Sign in to unlock the full Prosomnus Inc cash flow history.

About Prosomnus Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001558370-24-010492

Figures are derived from filed reports and may be restated. Historical data is subject to revision.